NEXGEL, INC. Amortization of Debt Issuance Costs and Discounts
NEXGEL, INC. (NXGL) reported Amortization of Debt Issuance Costs and Discounts of $1.32 million for the 12-month period ending 2022-12-31, per its 10-K filed 2024-04-10.
Discontinued › Cash Flow › Operating Activities
us-gaap:AmortizationOfFinancingCostsAndDiscounts · last filed 2024-04-10
- NEXGEL, INC. amortization of debt issuance costs and discounts for the quarter ending 2022-12-31 was -$1.00K, a 100.11% decline year-over-year.
- NEXGEL, INC. amortization of debt issuance costs and discounts for the quarter ending 2022-09-30 was $239.00K, a 54.91% decline year-over-year.
- NEXGEL, INC. amortization of debt issuance costs and discounts for the quarter ending 2022-06-30 was $345.00K, a 17.86% decline year-over-year.
- NEXGEL, INC. amortization of debt issuance costs and discounts for the quarter ending 2022-03-31 was $741.00K, a 586.11% increase year-over-year.
- NEXGEL, INC. amortization of debt issuance costs and discounts for fiscal 2022 was $1.32M, a 31.51% decline from fiscal 2021.
- NEXGEL, INC. amortization of debt issuance costs and discounts for fiscal 2021 was $1.93M, a 96550.00% increase from fiscal 2020.
- NEXGEL, INC. amortization of debt issuance costs and discounts for fiscal 2020 was $2.00K.
- NEXGEL, INC. amortization of debt issuance costs and discounts for fiscal 2019 was $0.00.
| Period end | Amortization of Debt Issuance Costs and Discounts 3 month | Amortization of Debt Issuance Costs and Discounts 6 month | Amortization of Debt Issuance Costs and Discounts 9 month | Amortization of Debt Issuance Costs and Discounts 12 month |
|---|---|---|---|---|
| 2022-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-10 | $238.00K derived: sum of 2 quarters · filed 2024-04-10 | $583.00K derived: sum of 3 quarters · filed 2024-04-10 | $1.32M 10-K · filed 2024-04-10 |
| 2022-09-30 | $239.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $584.00K derived: sum of 2 quarters · filed 2023-11-13 | $1.32M 10-Q · filed 2023-11-13 | $2.20M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $345.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $1.09M 10-Q · filed 2023-08-14 | $1.96M derived: sum of 3 quarters · filed 2023-08-14 | $2.49M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $741.00K 10-Q · filed 2023-05-15 | $1.62M derived: sum of 2 quarters · filed 2023-05-15 | $2.15M derived: sum of 3 quarters · filed 2023-05-15 | $2.57M derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $875.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | $1.41M derived: sum of 2 quarters · filed 2023-03-28 | $1.82M derived: sum of 3 quarters · filed 2023-03-28 | $1.93M 10-K · filed 2023-03-28 |
| 2021-09-30 | $530.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $950.00K derived: sum of 2 quarters · filed 2022-11-08 | $1.06M 10-Q · filed 2022-11-08 | $1.06M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $420.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $528.00K 10-Q · filed 2022-08-10 | $530.00K derived: sum of 3 quarters · filed 2022-08-10 | $530.00K derived: sum of 4 quarters · filed 2022-08-10 |
| 2021-03-31 | $108.00K 10-Q · filed 2022-05-13 | $110.00K derived: sum of 2 quarters · filed 2022-05-13 | $110.00K derived: sum of 3 quarters · filed 2022-05-13 | $110.00K derived: sum of 4 quarters · filed 2022-05-13 |
| 2020-12-31 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-21 | $2.00K derived: sum of 2 quarters · filed 2022-03-21 | $2.00K derived: sum of 3 quarters · filed 2022-03-21 | $2.00K 10-K · filed 2022-03-21 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $0.00 derived: sum of 2 quarters · filed 2021-11-10 | $0.00 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $0.00 10-Q · filed 2021-08-16 | ||
| 2020-03-31 | $0.00 10-Q · filed 2021-05-17 | |||
| 2019-12-31 | $0.00 10-K · filed 2021-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |